Eloxx Pharmaceuticals Inc (ELOX)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$

Buy

$

arrow-up$ (+%)

Prices updated at 14 Dec 2025, 09:15

Prices minimum 15 mins delay

Prices in USD

Eloxx Pharmaceuticals Inc is a United States-based clinical-stage pharmaceutical company. It is focused on building and developing a portfolio of therapeutics for the treatment of cancer and immunological diseases.

-%

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

Key dates

	Forecast date
Half yearly results	-
Annual report	Mar 2026
Final results	-
Annual general meeting	-

	Previous date
Annual report	Apr 2024

Company reports

31 Dec 2022

Annual Report

30 Sep 2023

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.